The dual-effects of PLGA@MT electrospun nanofiber coatings on promoting osteogenesis at the titanium–bone interface under diabetic conditions. Issue 21 (4th May 2022)
- Record Type:
- Journal Article
- Title:
- The dual-effects of PLGA@MT electrospun nanofiber coatings on promoting osteogenesis at the titanium–bone interface under diabetic conditions. Issue 21 (4th May 2022)
- Main Title:
- The dual-effects of PLGA@MT electrospun nanofiber coatings on promoting osteogenesis at the titanium–bone interface under diabetic conditions
- Authors:
- Wang, Zijie
Chen, Tingting
Wu, Zimei
Jiang, Xingzhu
Hou, Qiaodan
Miao, Sikai
Xia, Ruihao
Wang, Lin - Abstract:
- Abstract : A novel therapeutic strategy for promoting titanium–bone interface bone integration under diabetic conditions by fabricating PLGA@MT electrospun nanofiber coatings. Abstract : The high failure risk of endosseous titanium implants under diabetes conditions appeals to strengthen the osteointegration on the titanium–bone (Ti–B) interface. Melatonin (MT) is a neurohormone involved in bone homeostasis, which can promote osteogenesis and inhibit ROS overproduction through multiple pathways, but its effects on the Ti–B interface in diabetes remain elusive. The biodegradable poly(lactic- co -glycolic acid) (PLGA) has excellent controlled and sustained release properties, low cytotoxicity, and biocompatibility. Our study fabricated a nanofiber in which MT was encapsulated in PLGA to generate a nanofiber coating on a polydopamine (PDA)-modified titanium surface using electrospinning technology. The surface characteristic showed that MT was fully encapsulated in the PLGA carrier, and PLGA@MT was strongly coupled to the titanium matrix. Furthermore, the PLGA@MT-Ti nanofiber could release MT for at least 30 days. In vitro cellular tests demonstrated that PLGA@MT-Ti directly stimulates osteogenesis on the Ti–B interface by activating the BMP-4/WNT pathway in a dose-dependent manner. The effect of suppressing diabetes-induced ROS overproduction and promoting cell proliferation was not proportional to the content of MT. In vivo experiments revealed that PLGA@MT-Ti screws promotedAbstract : A novel therapeutic strategy for promoting titanium–bone interface bone integration under diabetic conditions by fabricating PLGA@MT electrospun nanofiber coatings. Abstract : The high failure risk of endosseous titanium implants under diabetes conditions appeals to strengthen the osteointegration on the titanium–bone (Ti–B) interface. Melatonin (MT) is a neurohormone involved in bone homeostasis, which can promote osteogenesis and inhibit ROS overproduction through multiple pathways, but its effects on the Ti–B interface in diabetes remain elusive. The biodegradable poly(lactic- co -glycolic acid) (PLGA) has excellent controlled and sustained release properties, low cytotoxicity, and biocompatibility. Our study fabricated a nanofiber in which MT was encapsulated in PLGA to generate a nanofiber coating on a polydopamine (PDA)-modified titanium surface using electrospinning technology. The surface characteristic showed that MT was fully encapsulated in the PLGA carrier, and PLGA@MT was strongly coupled to the titanium matrix. Furthermore, the PLGA@MT-Ti nanofiber could release MT for at least 30 days. In vitro cellular tests demonstrated that PLGA@MT-Ti directly stimulates osteogenesis on the Ti–B interface by activating the BMP-4/WNT pathway in a dose-dependent manner. The effect of suppressing diabetes-induced ROS overproduction and promoting cell proliferation was not proportional to the content of MT. In vivo experiments revealed that PLGA@MT-Ti screws promoted the bone formation and osteointegration in type 1 diabetes mellitus (T1DM) mice with tibial bone defects. Our findings demonstrate that PLGA@MT-Ti exerted dual effects through activating the BMP-4/WNT pathway and attenuating ROS overproduction to promote osteogenesis and osteointegration at the Ti–B interface, providing a novel strategy to fabricate biomaterial modification and biofunctionalization under diabetic conditions. … (more)
- Is Part Of:
- Journal of materials chemistry. Volume 10:Issue 21(2022)
- Journal:
- Journal of materials chemistry
- Issue:
- Volume 10:Issue 21(2022)
- Issue Display:
- Volume 10, Issue 21 (2022)
- Year:
- 2022
- Volume:
- 10
- Issue:
- 21
- Issue Sort Value:
- 2022-0010-0021-0000
- Page Start:
- 4020
- Page End:
- 4030
- Publication Date:
- 2022-05-04
- Subjects:
- Materials -- Periodicals
Chemistry, Analytic -- Periodicals
Biomedical materials -- Research -- Periodicals
543.0284 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/tb# ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d2tb00120a ↗
- Languages:
- English
- ISSNs:
- 2050-750X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5012.205200
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21770.xml